Follow
Alexandre de Titta, PhD
Alexandre de Titta, PhD
Bioengineer
Verified email at alumni.epfl.ch
Title
Cited by
Cited by
Year
Binding of silver nanoparticles to bacterial proteins depends on surface modifications and inhibits enzymatic activity
NS Wigginton, A de Titta, F Piccapietra, J Dobias, VJ Nesatyy, MJF Suter, ...
Environmental science & technology 44 (6), 2163-2168, 2010
3192010
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
A de Titta, M Ballester, Z Julier, C Nembrini, L Jeanbart, AJ van der Vlies, ...
Proceedings of the National Academy of Sciences 110 (49), 19902-19907, 2013
2922013
Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes
L Jeanbart, M Ballester, A de Titta, P Corthésy, P Romero, JA Hubbell, ...
Cancer immunology research 2 (5), 436-447, 2014
1912014
Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses
DJ Dowling, EA Scott, A Scheid, I Bergelson, S Joshi, C Pietrasanta, ...
Journal of Allergy and Clinical Immunology 140 (5), 1339-1350, 2017
1482017
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice
IC Kourtis, S Hirosue, A De Titta, S Kontos, T Stegmann, JA Hubbell, ...
PloS one 8 (4), e61646, 2013
1422013
Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis
M Ballester, C Nembrini, N Dhar, A de Titta, C De Piano, M Pasquier, ...
Vaccine 29 (40), 6959-6966, 2011
1322011
Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice
M Ballester, L Jeanbart, A de Titta, C Nembrini, BJ Marsland, JA Hubbell, ...
Scientific reports 5, 14274, 2015
492015
The TLR4 Agonist Fibronectin Extra Domain A is Cryptic, Exposed by Elastase-2; use in a fibrin matrix cancer vaccine
Z Julier, MM Martino, A de Titta, L Jeanbart, JA Hubbell
Scientific reports 5, 2015
492015
Engineering targeting materials for therapeutic cancer vaccines
PS Briquez, S Hauert, A de Titta, LT Gray, AT Alpar, MA Swartz, ...
Frontiers in bioengineering and biotechnology 8, 19, 2020
232020
Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses
Z Julier, A de Titta, AJ Grimm, E Simeoni, MA Swartz, JA Hubbell
Vaccine 34 (21), 2453-2459, 2016
212016
Phenology of Passerine bird migration in the Danube Delta, Romania
B Droz, S Joye, A de Titta, F Schneider, S Antoniazza
The Ring 38 (1), 25-42, 2016
52016
Adjuvant-free immunization with infective filarial larvae as lymphatic homing antigen carriers
C Card, DS Wilson, S Hirosue, M Rincon-Restrepo, A de Titta, E Güç, ...
Scientific reports 10 (1), 1055, 2020
12020
Reflets des résultats du camp international de baguage du Groupe des Jeunes de Nos Oiseaux dans le delta du Danube en 2007-2008
B Droz, A de Titta, F Schneider, S Antoniazza
Nos Oiseaux 1 (527), 64, 2017
2017
Dianhydrohexitol codrug
A DE TITTA, G De Visscher, M Takeiri, N Schüwer
2016
Compounds and formulations for the treatment of wounds
G De Visscher, W Eevers, N Schüwer, T Shigematsu, M Takeiri, ...
2016
Development of an extracellular matrix (ECM)-mimetic nanoparticle-based platform to deliver growth factors for inner ear regeneration
PS Briquez, A de Titta, C Takeda, JA Hubbell
Swiss Society for Biomaterials and Regenerative Medicine Annual Meeting 30 (S1), 2015
2015
Materials and protein engineering approaches for modulating immunity
J Hubbell, M Swartz, M Ballester, A de Titta, L Jeanbart, S Kontos, ...
Abstracts Of Papers Of The American Chemical Society 247 (EPFL-CONF-207222), 2014
2014
Engineering adjuvants for prophylactic and therapeutic subunit vaccines
A de Titta
EPFL, 2014
2014
Mechanisms of protein adhesion to bare and carbonate-coated silver nanoparticles
NS Wigginton, A de Titta, VJ Nesatyy, MJF Suter, R Bernier-Latmani
Geochimica et Cosmochimica Acta 73 (EML-CONF-2009-019), A1441, 2009
2009
Evaluating the use of nanoparticles as an antigen delivery system
A de Titta, M Tamborini, MA Swartz, G Pluschke, JA Hubbell
2008
The system can't perform the operation now. Try again later.
Articles 1–20